CP
About
Cannabics Pharmaceuticals (CNBX), a U.S based company, is dedicated to the development of Palliative and personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced screening systems and bioinformatic tools. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health and involves both scientific and academic research as well as current medical clinical studies
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 156 investors are based in Bethesda, Maryland, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Bethesda, US
Contact Information
Find more investors like Cannabics
Search Investors